| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| He Min, Linhua Yang, Xinsen Xu, Yajun Geng, Fatao Liu, Yingbin Li. SNHG15 promotes gallbladder cancer progression by enhancing the autophagy of tumor cell under nutrition stress. Cell cycle (Georgetown, Tex.). 2023-11-08. PMID:37937948. |
mechanistically, snhg15 could interact with ampk and facilitate the phosphorylation of ampk to tuberous sclerosis complex tsc2, resulting in mtor suppression and autophagy enhancement, and finally, conferring the gbc cell sustain proliferation under nutrition stress. |
2023-11-08 |
2023-11-20 |
Not clear |
| Inci S Aksoylu, Pauline Martin, Francis Robert, Krzysztof J Szkop, Nicholas E Redmond, Srirupa Bhattacharyya, Jennifer Wang, Shan Chen, Roberta L Beauchamp, Irene Nobeli, Jerry Pelletier, Ola Larsson, Vijaya Rames. Translatome analysis of tuberous sclerosis complex 1 patient-derived neural progenitor cells reveals rapamycin-dependent and independent alterations. Molecular autism. vol 14. issue 1. 2023-10-26. PMID:37880800. |
tuberous sclerosis complex (tsc) is an inherited neurocutaneous disorder caused by mutations in the tsc1 or tsc2 genes, with patients often exhibiting neurodevelopmental (nd) manifestations termed tsc-associated neuropsychiatric disorders (tand) including autism spectrum disorder (asd) and intellectual disability. |
2023-10-26 |
2023-11-08 |
Not clear |
| Georgios Papageorgiou, Nikolaos Skouteris, Christos Valavanis, Gabriela-Monica Stanc, Efthymia Souka, Nikolaos Charalampaki. Identification of a Novel TSC2 c.170G>A Missense Variant: A Case Report and Elaboration on the Yield of Targeted Options against Tuberous Sclerosis Complex Manifestations. Reviews on recent clinical trials. 2023-10-25. PMID:37877150. |
identification of a novel tsc2 c.170g>a missense variant: a case report and elaboration on the yield of targeted options against tuberous sclerosis complex manifestations. |
2023-10-25 |
2023-11-08 |
Not clear |
| Paolo Curatolo, Mirte Scheper, Leonardo Emberti Gialloreti, Nicola Specchio, Eleonora Aronic. Is tuberous sclerosis complex-associated autism a preventable and treatable disorder? World journal of pediatrics : WJP. 2023-10-25. PMID:37878130. |
tuberous sclerosis complex (tsc) is a genetic disorder caused by inactivating mutations in the tsc1 and tsc2 genes, causing overactivation of the mechanistic (previously referred to as mammalian) target of rapamycin (mtor) signaling pathway in fetal life. |
2023-10-25 |
2023-11-08 |
Not clear |
| Stephanie Deborah Fritsch, Nyamdelger Sukhbaatar, Karine Gonzales, Alishan Sahu, Loan Tran, Andrea Vogel, Mario Mazic, Jayne Louise Wilson, Stephan Forisch, Hannah Mayr, Raimund Oberle, Jakob Weiszmann, Martin Brenner, Roeland Vanhoutte, Melanie Hofmann, Sini Pirnes-Karhu, Christoph Magnes, Torben Kühnast, Wolfram Weckwerth, Christoph Bock, Kristaps Klavins, Markus Hengstschläger, Christine Moissl-Eichinger, Gernot Schabbauer, Gerda Egger, Eija Pirinen, Steven H L Verhelst, Thomas Weichhar. Metabolic support by macrophages sustains colonic epithelial homeostasis. Cell metabolism. 2023-10-07. PMID:37804836. |
specifically, deletion of tuberous sclerosis complex 2 (tsc2) in macrophages activated mtorc1 signaling that protected against colitis-induced intestinal damage and induced the synthesis of the polyamines spermidine and spermine. |
2023-10-07 |
2023-10-15 |
mouse |
| Chirag H Patel, Yi Dong, Navid Koleini, Xiaoxu Wang, Brittany L Dunkerly-Eyring, Jiayu Wen, Mark J Ranek, Laura M Bartle, Daniel B Henderson, Jason G Sagert, David A Kass, Jonathan D Powel. TSC2 S1365A mutation potently regulates CD8+T cell function and differentiation improving adoptive cellular cancer therapy. JCI insight. 2023-10-03. PMID:37788104. |
tsc2 in the tuberous sclerosis complex tightly regulates mtorc1 activation. |
2023-10-03 |
2023-10-07 |
human |
| Ashwini Sri Hari, Rajeswari Banerji, Li-Ping Liang, Ruth E Fulton, Christopher Quoc Huynh, Timothy Fabisiak, Pallavi Bhuyan McElroy, James R Roede, Manisha Pate. Increasing glutathione levels by a novel posttranslational mechanism inhibits neuronal hyperexcitability. Redox biology. vol 67. 2023-10-01. PMID:37769522. |
furthermore, bso-mediated gsh depletion oxidatively modified the tuberous sclerosis protein complex (tsc) consisting of hamartin (tsc1), tuberin (tsc2), and tbc1 domain family member 7 (tbc1d7) which are critical negative regulators of mtorc1. |
2023-10-01 |
2023-10-07 |
zebrafish |
| Gurneel K Dhanesar, Harish Rengarajan, Baidarbhi Chakrabort. Malignant Perivascular Epithelioid Cell Tumor of the Uterus. Cureus. vol 15. issue 7. 2023-08-14. PMID:37575749. |
they belong to the family of mesenchymal tumors and include angiomyolipomas, clear cell sugar tumors of the lung, and pecomas not otherwise specified (nos). tuberous sclerosis complex 1 (tsc1) and tuberous sclerosis complex 2 (tsc2) gene mutation is associated with pecoma, which causes hyperactivation of the mammalian target of rapamycin (mtor) signaling pathway. |
2023-08-14 |
2023-08-16 |
Not clear |
| Sameer C Dhamne, Meera E Modi, Audrey Gray, Simone Bonazzi, Lucas Craig, Elizabeth Bainbridge, Lahin Lalani, Chloe E Super, Samantha Schaeffer, Ketthsy Capre, Danuta Lubicka, Guiqing Liang, Doug Burdette, Stephanie M McTighe, Sarika Gurnani, Sheryl Anne D Vermudez, Daniel Curtis, Christopher J Wilson, Mustafa Q Hameed, Angelica D'Amore, Alexander Rotenberg, Mustafa Sahi. Seizure reduction in TSC2-mutant mouse model by an mTOR catalytic inhibitor. Annals of clinical and translational neurology. 2023-08-07. PMID:37545094. |
tuberous sclerosis complex (tsc) is a neurodevelopmental disorder caused by autosomal-dominant pathogenic variants in either the tsc1 or tsc2 gene, and it is characterized by hamartomas in multiple organs, such as skin, kidney, lung, and brain. |
2023-08-07 |
2023-08-14 |
mouse |
| Marjan Taherian, Paria Bayati, Mohammad-Ali Assarehzadegan, Mansoureh Soleimani, Hadi Poormoghim, Nazanin Mojtabav. Insights into Overlappings of Fibrosis and Cancer: Exploring the Tumor-related Cardinal Genes in Idiopathic Pulmonary Fibrosis. Iranian journal of allergy, asthma, and immunology. vol 22. issue 2. 2023-07-27. PMID:37496412. |
gene expression analyses indicated a significant elevation of regulatory associated protein of mtor (raptor), ras homolog enriched in brain (rheb), s6 kinase 1, and eukaryotic translation initiation factor 4e-binding protein 1 (4ebp1), as well as a significant reduction of vegfa, tuberous sclerosis complex (tsc2), and lrp1; no changes were observed in the tsc1 mrna level. |
2023-07-27 |
2023-08-14 |
mouse |
| Fang Qiu, Yun Luo, An-Ting Zhan, Fang-Gu Li, Yi-Ming Fa. Solitary scalp folliculocystic and collagen hamartoma caused by c.2353C>T TSC2 somatic mutation in a sporadic case of tuberous sclerosis complex with calvarial fibrous dysplasia. European journal of dermatology : EJD. vol 33. issue 2. 2023-07-11. PMID:37431128. |
solitary scalp folliculocystic and collagen hamartoma caused by c.2353c>t tsc2 somatic mutation in a sporadic case of tuberous sclerosis complex with calvarial fibrous dysplasia. |
2023-07-11 |
2023-08-14 |
Not clear |
| Erin Gibbons, Briaunna M N Minor, Stephen R Hamme. Lymphangioleiomyomatosis: where endocrinology, immunology and tumor biology meet. Endocrine-related cancer. 2023-07-06. PMID:37410387. |
lymphangioleiomyomatosis (lam) is a cystic lung disease found almost exclusively in genetic females and caused by small clusters of smooth muscle cell tumors containing mutations in one of the two tuberous sclerosis genes (tsc1 or tsc2). |
2023-07-06 |
2023-08-14 |
Not clear |
| Pooja Navale, Deyali Chatterjee, Malak Itani, Nikolaos A Trikalino. Tuberous sclerosis complex mutations in patients with pancreatic neuroendocrine tumors. Observations on phenotypic and treatment-related associations. Virchows Archiv : an international journal of pathology. 2023-06-24. PMID:37354253. |
pancreatic neuroendocrine tumors (pannets) in familial tuberous sclerosis (tsc1 and tsc2 mutations) have been known and studied. |
2023-06-24 |
2023-08-14 |
Not clear |
| Rebecca A Reynolds, Diane J Aum, Ignacio Gonzalez-Gomez, Michael Wong, Kaleigh Roberts, Sonika Dahiya, Luis F Rodriguez, Jarod L Roland, Matthew D Smyt. Subependymal giant-cell astrocytomas in the absence of tuberous sclerosis. Journal of neurosurgery. Pediatrics. 2023-06-17. PMID:37327147. |
tuberous sclerosis is a rare genetic condition caused by tsc1 or tsc2 mutations that can be inherited, sporadic, or the result of somatic mosaicism. |
2023-06-17 |
2023-08-14 |
Not clear |
| Kleanthi Chalkiadaki, Elpida Statoulla, Maria Zafeiri, Nabila Haji, Jean-Claude Lacaille, Craig M Powell, Seyed Mehdi Jafarnejad, Arkady Khoutorsky, Christos G Gkogka. Reversal of memory and autism-related phenotypes in Frontiers in cell and developmental biology. vol 11. 2023-06-09. PMID:37293130. |
reversal of memory and autism-related phenotypes in tuberous sclerosis complex (tsc) is a rare monogenic disorder co-diagnosed with high rates of autism and is caused by loss of function mutations in the tsc1 or tsc2 genes. |
2023-06-09 |
2023-08-14 |
mouse |
| Hiroki Ura, Sumihito Togi, Mamoru Ozaki, Hisayo Hatanaka, Yo Niid. Establishment of human induced pluripotent stem cell lines, KMUGMCi006, from a patient with Tuberous sclerosis complex (TSC) bearing mosaic nonsense mutations in the Tuberous sclerosis complex 2 (TSC2) gene. Stem cell research. vol 70. 2023-06-04. PMID:37271041. |
establishment of human induced pluripotent stem cell lines, kmugmci006, from a patient with tuberous sclerosis complex (tsc) bearing mosaic nonsense mutations in the tuberous sclerosis complex 2 (tsc2) gene. |
2023-06-04 |
2023-08-14 |
human |
| Hiroki Ura, Sumihito Togi, Mamoru Ozaki, Hisayo Hatanaka, Yo Niid. Establishment of human induced pluripotent stem cell lines, KMUGMCi006, from a patient with Tuberous sclerosis complex (TSC) bearing mosaic nonsense mutations in the Tuberous sclerosis complex 2 (TSC2) gene. Stem cell research. vol 70. 2023-06-04. PMID:37271041. |
tuberous sclerosis complex (tsc) is an autosomal dominant disorder characterized by neuropsychiatric symptoms and multiple dysplastic organ lesions, caused by loss of function mutations in either tsc1 or tsc2. |
2023-06-04 |
2023-08-14 |
human |
| Agung Triono, Elisabeth S Herini, Kristy Iskandar, Marissa L Hadiyanto, Kania Diantika, Veronica W Wijayanti, Gunad. De novo mutation of the TSC2 gene in patient with Tuberous Sclerosis Complex-Associated Neuropsychiatric Disorders (TAND) Phenotype: a case report. Annals of medicine and surgery (2012). vol 85. issue 5. 2023-05-25. PMID:37228977. |
de novo mutation of the tsc2 gene in patient with tuberous sclerosis complex-associated neuropsychiatric disorders (tand) phenotype: a case report. |
2023-05-25 |
2023-08-14 |
Not clear |
| Elisabetta Chiaradia, Ingrid Miller, Giovanni Renzone, Alessia Tognoloni, Alice Polchi, Federico De Marco, Brunella Tancini, Andrea Scaloni, Alessandro Magin. Proteomic analysis of murine Tsc1-deficient neural stem progenitor cells. Journal of proteomics. 2023-05-19. PMID:37207814. |
significance: tuberous sclerosis complex (tsc) is a multisystemic disorder caused by inactivating mutations of tsc1 or tsc2 genes, which induce overactivation of the mtor component. |
2023-05-19 |
2023-08-14 |
Not clear |
| Katarzyna Klonowska, Krinio Giannikou, Joannes M Grevelink, Barbara Boeszoermenyi, Aaron R Thorner, Zachary T Herbert, Antara Afrin, Alison M Treichel, Lana Hamieh, Katarzyna Kotulska, Sergiusz Jozwiak, Joel Moss, Thomas N Darling, David J Kwiatkowsk. Comprehensive genetic and phenotype analysis of 95 individuals with mosaic tuberous sclerosis complex. American journal of human genetics. 2023-05-04. PMID:37141891. |
tuberous sclerosis complex (tsc) is a neurogenetic disorder due to loss-of-function tsc1 or tsc2 variants, characterized by tumors affecting multiple organs, including skin, brain, heart, lung, and kidney. |
2023-05-04 |
2023-08-14 |
Not clear |